Wordwide To Drive The Newborn Metabolic Screening Market At A CAGR Of 9% From 2020-2030 - PowerPoint PPT Presentation

About This Presentation
Title:

Wordwide To Drive The Newborn Metabolic Screening Market At A CAGR Of 9% From 2020-2030

Description:

According to a latest report published by Persistence Market Research, the global newborn metabolic screening market was valued around US$ 247 Mn in 2020, and is expected to witness an impressive CAGR of over 9% during the forecast period (2020 – 2030). – PowerPoint PPT presentation

Number of Views:32

less

Transcript and Presenter's Notes

Title: Wordwide To Drive The Newborn Metabolic Screening Market At A CAGR Of 9% From 2020-2030


1
Newborn Metabolic Screening Market
Report Id PMRREP31998 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas


Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
Wordwide To Drive The Newborn Metabolic Screening
Market At A CAGR Of 9 From 2020-2030
  • Increasing birth rates across the world are
    expected to drive demand for newborn metabolic
    screening, as the risk of galactosemia, sickle
    cell disease, phenylketonuria, maple syrup urine
    disease, and cystic fibrosis is higher among
    infants. Various countries are implementing
    screening for metabolic diseases in newborns as a
    part of their immunization programs. To remain
    competitive and ensure a robust product pipeline,
    leading companies continue to identify potential
    assets through pilot screening programs, which
    typically have limited resources to see projects
    through the market.
  • According to a latest report published by
    Persistence Market Research, the global newborn
    metabolic screening market was valued around US
    247 Mn in 2020, and is expected to witness an
    impressive CAGR of over 9 during the forecast
    period (2020 2030).

Get Sample Copy of Report _at_ https//www.persistenc
emarketresearch.com/samples/31998
4
Collaborations Acquisitions Key Strategies
amongst Market Players
  • Leading players in the newborn metabolic
    screening landscape are focusing on improving
    their product portfolios through partnerships and
    acquisitions. Various players are also focusing
    on regulatory approvals and innovative product
    launches.
  • On October 05, 2020, PerkinElmer announced CE-IVD
    approval of the EONIS newborn screening assay.
  • In October 2018, Trivitrons Labsystems
    Diagnostics launched high quality newborn
    screening panels.
  • On September 3, 2020, Sickle SCAN was approved
    by the Department of Health in Australia.

Access Full Report _at_ https//www.persistencemarket
research.com/checkout/31998
5
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com